⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | DSP Large & Mid Cap Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | DSP MF | HDFC MF |
| Category | Equity - Large & Mid Cap Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹657.56 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★★ | ★★★★★ |
| Benchmark | NIFTY LargeMidcap 250 - TRI | BSE Health Care - TRI |
| Fund Manager | Rohit Singhania | Nikhil Mathur |
| Inception | 01 Jan 2013 | 04 Oct 2023 |
| Returns | ||
| 1Y | -7.37% | 22.64% |
| 3Y | 12.87% | 30.41% |
| 5Y | 10.91% | — |
| Since Inception | 15.32% | 29.15% |
| Risk | ||
| 14.28 | 14.07 | |
| 0.96 | 0.59 | |
| 0.44 | 1.59 | |
| 1.30 | 21.67 | |
| 0.84 | 3.48 | |
| -12.39% | -9.23% | |
| Costs | ||
| Expense Ratio | 0.79% | 1.03% |
| Exit Load | NIL upto 10% of units and 1% for remaining units on or before 1M, NIL after 1M | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹100 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
DSP MF96%
HDFC MF96%
3.6%Only 3.6% of holdings by weight are common between DSP MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingDSP MFHDFC MF
Alkem Laboratories Ltd.1.96%4.64%
Ipca Laboratories Ltd.1.60%2.98%
Category context: Equity vs Equity. Open the full Screener →